搜索临床试验以:bevacizumab erlotinib hydrochloride
总计10079个结果
-
Pfizer完全的癌,非小细胞肺癌美国, 加拿大, 波兰, 罗马尼亚, 意大利, 西班牙, 荷兰, 匈牙利
-
National Cancer Institute (NCI)完全的复发性肾细胞癌 | III期肾细胞癌 | IV 期肾细胞癌 | 1 型乳头状肾细胞癌 | 2 型乳头状肾细胞癌美国
-
AbbVie (prior sponsor, Abbott)完全的
-
Tongji HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Tragara Pharmaceuticals, Inc.完全的
-
Royal Marsden NHS Foundation TrustHoffmann-La Roche; Professor Cunningham's Clinical Research Fund完全的
-
SCRI Development Innovations, LLCGenentech, Inc.完全的
-
The University of Texas Health Science Center at...National Cancer Institute (NCI)完全的
-
The First Affiliated Hospital of Guangzhou Medical...尚未招聘
-
M.D. Anderson Cancer CenterNovartis; OSI Pharmaceuticals终止
-
University of California, DavisNational Cancer Institute (NCI); Genentech, Inc.完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Yonggao MouThe First Affiliated Hospital of Nanchang University招聘中
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Chinese Lung Cancer Surgical GroupZhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; Chinese PLA General Hospital; Peking... 和其他合作者未知
-
National Cancer Center, KoreaPfizer; Roche Pharma AG未知
-
Mayo Clinic完全的转移性结直肠腺癌 | 转移性结肠腺癌 | 转移性结直肠癌 | 转移性直肠腺癌 | IV 期结直肠癌 AJCC v8 | IVA 期结直肠癌 AJCC v8 | IVB 期结直肠癌 AJCC v8 | IVC 期结直肠癌 AJCC v8 | 转移性微卫星稳定性结直肠癌 | 转移性微卫星稳定性结肠癌 | 微卫星稳定性直肠癌美国
-
Guangdong Provincial People's Hospital未知
-
Indiana University School of MedicineGenentech, Inc.完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的IV 期结直肠癌 AJCC v7 | IVA 期结直肠癌 AJCC v7 | IVB 期结直肠癌 AJCC v7 | 转移性结直肠癌 | III 期结肠癌 AJCC v7 | III 期直肠癌 AJCC v7 | IIIA 期结肠癌 AJCC v7 | IIIA 期直肠癌 AJCC v7 | IIIB 期结肠癌 AJCC v7 | IIIB 期直肠癌 AJCC v7 | IIIC 期结肠癌 AJCC v7 | IIIC 期直肠癌 AJCC v7 | IV 期结肠癌 AJCC v7 | IV 期直肠癌 AJCC v7 | IVA 期结肠癌 AJCC v7 | IVA 期直肠癌 AJCC v7 | IVB 期结肠癌 AJCC v7 | IVB 期直肠癌 AJCC v7 | III 期结直肠癌... 及其他条件美国
-
M.D. Anderson Cancer CenterUnited States Department of Defense; Genentech, Inc.完全的
-
Herbert J. Zeh, III MD, FACSGenentech, Inc.终止